foxo4-dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI ES2 disrupts FOXO4 foci and
ES2 disrupts FOXO4 foci and localizes to FOXO4 foci. a, Representative Download Scientific Diagram FOXO4 D Retro Inverso(DRI) peptide FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





